The respiratory consequences of COVID-19 lasted for a median of 4 months in a cohort of children aged 2-18 years of age
Jazyk angličtina Země Norsko Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie
Grantová podpora
[UNCE 204064]
Univerzita Karlova v Praze
PubMed
35175667
PubMed Central
PMC9111221
DOI
10.1111/apa.16297
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, chronic cough, coronavirus, dyspnoea, post-COVID syndrome,
- MeSH
- bolesti na hrudi MeSH
- COVID-19 * komplikace MeSH
- dítě MeSH
- dyspnoe MeSH
- kašel MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- SARS-CoV-2 MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
AIM: We focused on the clinical picture, severity and prognosis of children who experienced long-term respiratory issues after COVID-19. METHODS: This was a national Czech multicentre study of paediatric post-COVID syndrome, which used a standard protocol to evaluate structural and functional anomalies and exclude alternative diagnoses. From 6 January to 30 June 2021, 11 paediatric pulmonologists enrolled all paediatric referrals aged 2-18 years with persistent respiratory symptoms more than 12 weeks after COVID-19, namely cough, dyspnoea and chest pain. Medical histories were taken, and physical examinations, lung function testing, chest X-ray and blood tests were performed. RESULTS: The dominant symptoms in the 39 children (56.4% girls) were exertional dyspnoea (76.9%) and a chronic cough (48.7%), while dyspnoea at rest (30.8%) and chest pain (17.9%) were less prevalent. More than half (53.8%) reported more than 1 symptom, and 38.5% had abnormal results for 1 of the following tests: lung function, chest X-ray or D-dimers. The median age of the children was 13.5 years (interquartile range ±4.8 years), and the median recovery time was 4 months (range 1.5-8 months). CONCLUSION: Our initial data suggest that the long-term respiratory impact of COVID-19 was relatively mild in our cohort, with a favourable prognosis.
Zobrazit více v PubMed
COVID‐19 in the Czech Republic according to age CoVdata [Internet]. [cited 2022 Jan 16]. Available from: https://www.covdata.cz/cesko‐vek.php
Population | CZSO [Internet]. [cited 2022 Jan 13]. Available from: https://www.czso.cz/csu/czso/population
Netea MG, Giamarellos‐Bourboulis EJ, Domínguez‐Andrés J, et al. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS‐CoV‐2 Infection. Cell Press. 2020;181:969‐977. PubMed PMC
Yong SJ. Long COVID or post‐COVID‐19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737‐754. PubMed PMC
Fernández‐de‐las‐Peñas C, Palacios‐Ceña D, Gómez‐Mayordomo V, et al. Prevalence of post‐COVID‐19 symptoms in hospitalized and non‐hospitalized COVID‐19 survivors: A systematic review and meta‐analysis. Eur J Intern Med. 2021;92:55‐70. PubMed PMC
Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid‐19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:136. PubMed
Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS‐CoV‐2 infection amongst children and young people: A meta‐analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158‐170. PubMed PMC
Santos MO, Gonçalves LC, Silva PAN, et al. Multisystem inflammatory syndrome (MIS‐C): a systematic review and meta‐analysis of clinical characteristics, treatment, and outcomes. Jornal De Pediatria. 2021;8:6. PubMed PMC
Ludvigsson JF. Case report and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19. Acta Paediatr. 2021;110:914‐921. PubMed PMC
Brackel CLH, Lap CR, Buddingh EP, et al. Pediatric long‐COVID: An overlooked phenomenon? Pediatr Pulmonol. 2021;56:2495‐2502. PubMed PMC
Radtke T, Ulyte A, Puhan MA, Kriemler S. Long‐term Symptoms After SARS‐CoV‐2 Infection in Children and Adolescents. JAMA. 2021;326(9):869. PubMed PMC
Buonsenso D, Munblit D, de Rose C, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208‐2211. PubMed PMC
Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school‐aged children tested for SARS‐CoV‐2. The Lancet Child & Adolescent. Health. 2021;5(10):708‐718. PubMed PMC
Torres‐Castro R, Vasconcello‐Castillo L, Alsina‐Restoy X, et al. Respiratory function in patients post‐infection by COVID‐19: a systematic review and meta‐analysis. Pulmonology. 2021;27(4):328‐337. PubMed PMC
Naeije R, Caravita S. Phenotyping long COVID. Eur Respir J. 2021;63:58. PubMed PMC
Czechia: Coronavirus Pandemic Country Profile ‐ Our World in Data [Internet]. [cited 2022 Jan 16]. Available from: https://ourworldindata.org/coronavirus/country/czech‐republic